Cargando…
Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients
Autores principales: | Sims, Jonathan T., Chang, Ching-Yun, Poorbaugh, Josh, Daniels, Montanea, Beasley, Stephanie L., Zhang, Lin, Rodgers, George H., Lena, Fabio, Lacerenza, Leonardo G., Sposato, Bruno, Dupont, Annabelle, Susen, Sophie, Casalini, Giacomo, Corbellino, Mario, Stebbing, Justin, Krishnan, Venkatesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458306/ https://www.ncbi.nlm.nih.gov/pubmed/36076201 http://dx.doi.org/10.1186/s12967-022-03583-5 |
Ejemplares similares
-
Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
por: Sims, Jonathan T., et al.
Publicado: (2021) -
CNS penetration of potential anti-COVID-19 drugs
por: Richardson, Peter J., et al.
Publicado: (2020) -
Drugs for paediatric hyperinflammatory syndromes
por: Hon, Kam Lun, et al.
Publicado: (2022) -
The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination
por: Benschop, Robert J., et al.
Publicado: (2022) -
Haemophagocytic lymphohisticytosis—an underrecognized hyperinflammatory syndrome
por: Hutchinson, Matthew, et al.
Publicado: (2019)